Eli Lilly says it has asked the U.S. government to allow emergency use of an experimental antibody therapy based on early results from a study that suggested the drug reduced symptoms, the amount of virus, hospitalizations and ER visits for patients with mild or moderate COVID-19.
from Section Page News - Modern Healthcare https://ift.tt/3jI2tN6
via IFTTT
No comments:
Post a Comment